4
Changes in Ownership
LISATA THERAPEUTICS, INC. Filed Acc 0001144204-18-020002
Options or other derivatives
- Chief Executive Officer acquired 33,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Mazzo David J · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-04-06 | Grant or award : show line 1 in the form Performance Rights | +33,300 | 33,300 | D |
Loading xslF345X03/tv490823_4.xml…